CNBC January 21, 2026
Key Points
– OpenEvidence raised money at a valuation of $12 billion in a round led by Thrive and DST.
– The startup is widely known as “ChatGPT for doctors” and has seen meteoric growth from its $1 billion valuation a year ago.
– CEO Daniel Nadler told CNBC that OpenEvidence is used by 40% of physicians in the U.S. and topped $100 million in annual revenue last year.
A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion.
OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled...
Today's Sponsors
Today's Sponsor